Update in Intracerebral Hemorrhage

The Neurohospitalist

Volumn 1, Issue 3, 2011, Pages 148-159

  Aguilar, Maria I ^a   Brott, Thomas G ^b  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

diagnosis; intracerebral hemorrhage; prognosis; surgery; treatment

Indexed keywords

EID: 84992863126     PISSN: 19418744     EISSN: 19418752     Source Type: Journal    
DOI: 10.1177/1941875211409050     Document Type: Review

References (98)

1. Flaherty ML Woo D Haverbusch M, et al. Racial variations in location and risk of intracerebral hemorrhage. Stroke. 2005; 36(5):934–937.
2. Grysiewicz RA Thomas K Pandey DK. Epidemiology of ischemic and hemorrhagic stroke: incidence, prevalence, mortality, and risk factors. Neurol Clin. 2008; 26(4):871–895.
3. Broderick JP Adams HP Jr Barsan W, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 1999; 30(4):905–915.
4. Gebel JM Broderick JP. Intracerebral hemorrhage. Neurol Clin. 2000; 18(2):419–438.
5. Qureshi AI Tuhrim S Broderick JP Batjer HH Hondo H Hanley DF. Spontaneous intracerebral hemorrhage. [see comment]. N Engl J Med. 2001; 344(19):1450–1460.
6. Inagawa T Ohbayashi N Takechi A Shibukawa M Yahara K. Primary intracerebral hemorrhage in Izumo City, Japan: incidence rates and outcome in relation to the site of hemorrhage. Neurosurgery. 2003; 53(6):1283–1297; discussion 1297-1288.
7. Fisher CM. Pathological observations in hypertensive cerebral hemorrhage. J NeuropatholExp Neurol. 1971; 30(3):536–550.
8. Feldmann E Tornabene J. Diagnosis and treatment of cerebral amyloid angiopathy. Clin Geriatr Med. 1991; 7(3):617–630.
9. Itoh Y Yamada M Hayakawa M Otomo E Miyatake T. Cerebral amyloid angiopathy: a significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderly. J Neurol Sci. 1993; 116(2):135–141.
10. Neau JP Ingrand P Couderq C, et al. Recurrent intracerebral hemorrhage. Neurology. 1997; 49(1):106–113.
11. O’Donnell HC Rosand J Knudsen KA, et al. Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. N Engl J Med. 2000; 342(4):240–245.
12. Passero S Burgalassi L D’Andrea P Battistini N. Recurrence of bleeding in patients with primary intracerebral hemorrhage. Stroke. 1995; 26(7):1189–1192.
13. Fang MC Chang Y Hylek EM, et al. Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation [see comment] [summary for patients in. Ann Intern Med. 2004; 141(10):I38;
14. PMID: 15545670]. Ann Intern Med. 2004; 141(10):745–752.
15. del Zoppo GJ Mori E. Hematologic causes of intracerebral hemorrhage and their treatment. Neurosurg Clin N Am. 1992; 3(3):637–658.
16. Hart RG Boop BS Anderson DC. Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses. Stroke. 1995; 26(8):1471–1477.
17. Aguilar MI Hart RG Kase CS, et al. Treatment of Warfarin-associated intracerebral hemorrhage: litearure review and expert opinion. Mayo Clin Proc. 2007; 82(1):82–92.
18. Neau JP Couderq C Ingrand P Blanchon P Gil R VGP Study Group. Intracranial hemorrhage and oral anticoagulant treatment. Cerebrovasc Dis. 2001; 11(3):195–200.
19. Walsh S. FDA Approves Pradaxa to Prevent Stroke in People With Atrial Fibrillation. FDA; 2010. http://www.fda.gov/NewsEvents/Newsroom/Press Announcements/ucm230241.htm
20. Ezekowitz MD Connolly S Parekh A, et al. Rationale and design of RE-LY: randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran. Am Heart J. 2009; 157(5):805–810.
21. Wallentin L Yusuf S Ezekowitz MD, et al. Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial. Lancet. 2010; 376(9745):975–983.
22. Connolly SJ Ezekowitz MD Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009; 361(12):1139–1151.
23. Stangier J Clemens A. Pharmacology, pharmacokinetics, and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor. Clin Appl Thromb Hemost. 2009; 15(suppl 1):9S–16S.
24. Inzitari D Giordano GP Ancona AL Pracucci G Mascalchi M Amaducci L. Leukoaraiosis, intracerebral hemorrhage, and arterial hypertension. Stroke. 1990; 21(10):1419–1423.
25. Lou M Al-Hazzani A Goddeau RP Jr Novak V Selim M. Relationship between white-matter hyperintensities and hematoma volume and growth in patients with intracerebral hemorrhage. Stroke. 2010; 41(1):34–40.
26. Aguilar MI O’Meara ES Seliger S, et al. Albuminuria and the risk of incident stroke and stroke types in older adults. Neurology. 2010; 75(15):1343–1350.
27. Gorelick PB. Alcohol and stroke. Stroke. 1987; 18(1):268–271.
28. McEvoy AW Kitchen ND Thomas DG. Intracerebral haemorrhage and drug abuse in young adults. Br J Neurosurg. 2000; 14(5):449–454.
29. McEvoy AW Kitchen ND Thomas DG. Lesson of the week: intracerebral haemorrhage in young adults: the emerging importance of drug misuse. BMJ. 2000; 320(7245): 1322–1324.
30. Aggarwal SK Williams V Levine SR Cassin BJ Garcia JH. Cocaine-associated intracranial hemorrhage: absence of vasculitis in 14 cases. Neurology. 1996; 46(6):1741–1743.
31. Calabrese LH Dodick DW Schwedt TJ Singhal AB. Narrative review: reversible cerebral vasoconstriction syndromes. Ann Intern Med. 2007; 146(1):34–44.
32. Nolte KB Brass LM Fletterick CF. Intracranial hemorrhage associated with cocaine abuse: a prospective autopsy study. Neurology. 1996; 46(5):1291–1296.
33. Toossi S Hess CP Hills NK Josephson SA. Neurovascular complications of cocaine use at a tertiary stroke center. J Stroke Cerebrovasc Dis. 19(4):273–278.
34. Collins R Armitage J Parish S Sleight P Peto R Heart Protection Study Collaborative G. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions [see comment]. Lancet. 2004; 363(9411):757–767.
35. Amarenco P Bogousslavsky J Callahan A 3rd, et al. High-dose atorvastatin after stroke or transient ischemic attack [see comment]. N Engl J Med. 2006; 355(6):549–559.
36. Amarenco P Labreuche J Lavallee P Touboul PJ. Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis. Stroke. 2004; 35(12): 2902–2909.
37. Moulakakis KG Mylonas SN Sfyroeras GS Andrikopoulos V. Hyperperfusion syndrome after carotid revascularization. J Vasc Surg. 2009; 49(4):1060–1068.
38. Mandybur TI. Cerebral amyloid angiopathy: the vascular pathology and complications. J Neuropathol Exp Neurol. 1986; 45(1):79–90.
39. Vinters HV Natté R Maat-Schieman ML, et al. Secondary microvascular degeneration in amyloid angiopathy of patients with hereditary cerebral hemorrhage with amyloidosis, Dutch type (HCHWA-D). Acta Neuropathol. 1998; 95(3):235–244.
40. Kazui S Naritomi H Yamamoto H Sawada T Yamaguchi T. Enlargement of spontaneous intracerebral hemorrhage. Incidence and time course. Stroke. 1996; 27(10):1783–1787.
41. Yasaka M Minematsu K Naritomi H Sakata T Yamaguchi T. Predisposing factors for enlargement of intracerebral hemorrhage in patients treated with warfarin. Thromb Haemost. 2003; 89(2):278–283.
42. Zazulia AR Diringer MN Derdeyn CP Powers WJ. Progression of mass effect after intracerebral hemorrhage. Stroke. 1999; 30(6):1167–1173.
43. Wagner KR Xi G Hua Y Kleinholz M de Courten-Myers GM Myers RE. Early metabolic alterations in edematous perihematomal brain regions following experimental intracerebral hemorrhage. J Neurosurg. 1998; 88(6):1058–1065.
44. Bullock R Mendelow AD Teasdale GM Graham DI. Intracranial haemorrhage induced at arterial pressure in the rat. Part 1: description of technique, ICP changes and neuropathological findings. Neurol Res. 1984; 6(4):184–188.
45. Mendelow AD Bullock R Teasdale GM Graham DI McCulloch J. Intracranial haemorrhage induced at arterial pressure in the rat. Part 2: short term changes in local cerebral blood flow measured by autoradiography. Neurol Res. 1984; 6(4):189–193.
46. Rosand J Eskey C Chang Y Gonzalez RG Greenberg SM Koroshetz WJ. Dynamic single-section CT demonstrates reduced cerebral blood flow in acute intracerebral hemorrhage. Cerebrovas Dis. 2002; 14(3-4):214–220.
47. Siddique MS Fernandes HM Wooldridge TD Fenwick JD Slomka P Mendelow AD. Reversible ischemia around intracerebral hemorrhage: a single-photon emission computerized tomography study. J Neurosurg. 2002; 96(4):736–741.
48. Uemura K Shishido F Higano S, et al. Positron emission tomography in patients with a primary intracerebral hematoma. Acta Radiol Suppl. 1986; 369: 426–428.
49. Powers WJ Zazulia AR Videen TO, et al. Autoregulation of cerebral blood flow surrounding acute (6 to 22 hours) intracerebral hemorrhage. Neurology. 2001; 57(1):18–24.
50. Videen TO Dunford-Shore JE Diringer MN Powers WJ. Correction for partial volume effects in regional blood flow measurements adjacent to hematomas in humans with intracerebral hemorrhage: implementation and validation. J Comput Assist Tomogr. 1999; 23(2):248–256.
51. Zazulia AR Diringer MN Videen TO, et al. Hypoperfusion without ischemia surrounding acute intracerebral hemorrhage. J Cereb Blood Flow Metab. 2001; 21(7):804–810.
52. Schellinger PD Fiebach JB Hoffmann K, et al. Stroke MRI in Intracerebral hemorrhage: is there a perihemorrhagic penumbra?. Stroke. 2003; 34(7):1674–1679.
53. Tayal AH Gupta R Yonas H, et al. Quantitative perihematomal blood flow in spontaneous intracerebral hemorrhage predicts in-hospital functional outcome. Stroke. 2007; 38(2):319–324.
54. Kidwell CS Saver JL Mattiello J, et al. Diffusion-perfusion MR evaluation of perihematomal injury in hyperacute intracerebral hemorrhage. Neurology. 2001; 57(9):1611–1617.
55. Arboix A Comes E Garcia-Eroles L, et al. Site of bleeding and early outcome in primary intracerebral hemorrhage. Acta Neurol Scand. 2002; 105(4):282–288.
56. Broderick J Connolly S Feldmann E, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke. 2007; 38(6):2001–2023.
57. Iyer VN Mandrekar JN Danielson RD Zubkov AY Elmer JL Wijdicks EF. Validity of the FOUR score coma scale in the medical intensive care unit. Mayo Clin Proc. 2009; 84(8):694–701.
58. Morgenstern LB Hemphill 3rd JC Anderson C, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2010; 41(9):2108–2129.
59. Bradley Jr WG. MR appearance of hemorrhage in the brain. Radiology. 1993; 189(1):15–26.
60. Wada R Aviv RI Fox AJ, et al. CT angiography “spot sign” predicts hematoma expansion in acute intracerebral hemorrhage. Stroke. 2007; 38(4):1257–1262.
61. Kreel L Kay R Woo J Wong HY Nicholls MG. The radiological (CT) and clinical sequelae of primary intracerebral haemorrhage. Br J Radiol. 1991; 64(768):1096–1100.
62. Broderick JP Brott TG Duldner JE Tomsick T Huster G. Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality [see comment]. Stroke. 1993; 24(7):987–993.
63. Kothari RU Brott T Broderick JP, et al. The ABCs of measuring intracerebral hemorrhage volumes. Stroke. 1996; 27(8):1304–1305.
64. Ronning P Sorteberg W Nakstad P Russell D Helseth E. Aspects of intracerebral hematomas—an update. Acta Neurol Scand. 2008; 118(6):347–361.
65. Fazekas F Kleinert R Roob G, et al. Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. AJNR Am J Neuroradiol. 1999; 20(4):637–642.
66. Roob G Lechner A Schmidt R Flooh E Hartung HP Fazekas F. Frequency and location of microbleeds in patients with primary intracerebral hemorrhage. Stroke. 2000; 31(11): 2665–2669.
67. Roob G Schmidt R Kapeller P Lechner A Hartung HP Fazekas F. MRI evidence of past cerebral microbleeds in a healthy elderly population. Neurology. 1999; 52(5):991–994.
68. Aguilar MI Demaerschalk BM. Intracerebral hemorrhage. Semin Neurol. 2007; 27(4):376–384.
69. Singhal AB. Cerebral vasoconstriction without subarachnoid blood: associated conditions, clinical and neuroimaging characteristics. Ann Neurol. 2002; 52(3S):S58–S63.
70. Dodick DW. Reversible segmental cerebral vasoconstriction (Call-Fleming syndrome): the role of calcium antagonists. Cephalalgia. 2003; 23(3):163–165.
71. Broderick JP Brott T Tomsick T Huster G Miller R. The risk of subarachnoid and intracerebral hemorrhages in blacks as compared with whites. N Engl J Med. 1992; 326(11): 733–736.
72. Vermeer SE Algra A Franke CL Koudstaal PJ Rinkel GJ. Long-term prognosis after recovery from primary intracerebral hemorrhage. Neurology. 2002; 59(2):205–209.
73. Hemphill 3rd JC Bonovich DC Besmertis L Manley GT Johnston SC. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage [see comment]. Stroke. 2001; 32(4):891–897.
74. Hill MD Silver FL Austin PC Tu JV. Rate of stroke recurrence in patients with primary intracerebral hemorrhage. Stroke. 2000; 31(1):123–127.
75. Bae H Jeong D Doh J Lee K Yun I Byun B. Recurrence of bleeding in patients with hypertensive intracerebral hemorrhage. Cerebrovasc Dis. 1999; 9(2):102–108.
76. Brott T Thalinger K Hertzberg V. Hypertension as a risk factor for spontaneous intracerebral hemorrhage. Stroke. 1986; 17(6):1078–1083.
77. Okada H Horibe H Yoshiyuki O Hayakawa N Aoki N. A prospective study of cerebrovascular disease in Japanese rural communities, Akabane and Asahi. Part 1: evaluation of risk factors in the occurrence of cerebral hemorrhage and thrombosis. Stroke. 1976; 7(6):599–607.
78. Hanger HC Wilkinson TJ Fayez-Iskander N Sainsbury R. The risk of recurrent stroke after intracerebral haemorrhage. J Neurol, Neurosurg Psychiatry. 2007; 78(8):836–840.
79. Diringer MN Edwards DF. Admission to a neurologic/neurosurgical intensive care unit is associated with reduced mortality rate after intracerebral hemorrhage [see comment]. Crit Care Med. 2001; 29(3):635–640.
80. Flibotte JJ Hagan N O’Donnell J Greenberg SM Rosand J. Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology. 2004; 63(6):1059–1064.
81. Flaherty ML Haverbusch M Sekar P, et al. Location and outcome of anticoagulant-associated intracerebral hemorrhage. Neurocrit Care. 2006; 5(3):197–201.
82. Flaherty ML Haverbusch M Sekar P, et al. The Increasing burden of anticoagulant-associated intracerebral hemorrhage. Stroke. 2006; 37(2):623.
83. Flaherty ML Kissela B Woo D, et al. The increasing incidence of anticoagulant-associated intracerebral hemorrhage. Neurology. 2007; 68(2):116–121.
84. Hellstern P. Production and composition of prothrombin complex concentrates: correlation between composition and therapeutic efficiency. Thromb Res. 1999; 95(4 suppl 1):S7–S12.
85. Hellstern P Halbmayer WM Kohler M Seitz R Muller-Berghaus G. Prothrombin complex concentrates: indications, contraindications, and risks: a task force summary. Thromb Res. 1999; 95(4 suppl 1):S3–S6.
86. Mayer SA Brun NC Begtrup K, et al. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2005; 352(8):777–785.
87. Mayer SA Brun NC Begtrup K, et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage [comment]. N Engl J Med. 2008; 358(20):2127–2137.
88. Jauch EC Lindsell CJ Adeoye O, et al. Lack of evidence for an association between hemodynamic variables and hematoma growth in spontaneous intracerebral hemorrhage. Stroke. 2006; 37(8):2061–2065.
89. Qureshi AI. Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH): rationale and design. Neurocrit Care. 2007; 6(1):56–66.
90. Anderson CS Huang Y Wang JG, et al. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol. 2008; 7(5):391–399.
91. Passero S Rocchi R Rossi S Ulivelli M Vatti G. Seizures after spontaneous supratentorial intracerebral hemorrhage. Epilepsia. 2002; 43(10):1175–1180.
92. Lyden PD Shuaib A Lees KR, et al. Safety and tolerability of NXY-059 for acute intracerebral hemorrhage: the CHANT Trial. Stroke. 2007; 38(8):2262–2269.
93. Morgan T Zuccarello M Narayan R Keyl P Lane K Hanley D. Preliminary findings of the minimally-invasive surgery plus rtPA for intracerebral hemorrhage evacuation (MISTIE) clinical trial. Acta Neurochir Suppl. 2008; 105: 147–151.
94. Nishihara T Nagata K Tanaka S, et al. Newly developed endoscopic instruments for the removal of intracerebral hematoma. Neurocrit Care. 2005; 2(1):67–74.
95. Vespa P McArthur D Miller C, et al. Frameless stereotactic aspiration and thrombolysis of deep intracerebral hemorrhage is associated with reduction of hemorrhage volume and neurological improvement. Neurocrit Care. 2005; 2(3): 274–281.
96. Mendelow AD Gregson BA Fernandes HM, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial [see comment]. Lancet. 2005; 365(9457): 387–397.
97. Hanley D. Final results of CLEAR IVH trial: clot lysis, safety, and functional outcomes. Cerebrovasc Dis. 2008; 25(suppl 2):9.
98. Gorter JW. Major bleeding during anticoagulation after cerebral ischemia: patterns and risk factors. Stroke Prevention In Reversible Ischemia Trial (SPIRIT). European Atrial Fibrillation Trial (EAFT) study groups. Neurology. 1999; 53(6): 1319–1327.